Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share Institutional Ownership

Q: What is CUSIP M8769Q102?

CUSIP M8769Q102 is the security identifier used in SEC filing datasets for M8769Q102 - Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share.

Q: Who owns M8769Q102 - Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: M8769Q102

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class: Equity / Ordinary Shares, par value NIS 0.10 per share
Shares outstanding: 1,148,024,683
All holders as of 31 Dec 2025: Q4 2025
Total 13F shares: 0
Total reported value: $0
Share change: -31,565
Value change: -$637,613
Number of holders: 0

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP M8769Q102?
CUSIP M8769Q102 identifies M8769Q102 - Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP M8769Q102:

Q4 2025 (0 holders) Q3 2025 (1 holder) Q2 2025 (1 holder)

Significant Owners of Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Harel Insurance Investments & Financial Services Ltd.	6.3%	+24%		+$286,988,127	72,325,555	+24%	Harel Insurance Investments & Financial Services Ltd	31 Dec 2025
FMR LLC	2.1%	-60%		-$561,363,714	24,641,361	-58%	FMR LLC	30 Sep 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share. This represents 0% of the company’s total 1,148,024,683 outstanding shares.

Institutional Holders of Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2025 Q4	0	$0	-$637,613		0
2025 Q3	31,565	$637,613	-$257,126	$20.20	1
2025 Q2	44,294	$742,367	+$742,367	$16.76	1